1Peres L A, da Cunha A D Jr. Acute nephrotoxicity of cisplatin: molecular mechanisms [ J ]. J Bras Nefrol ,2013 ,35 (4) : 332-340.
2Ramesh G, Ranganathan P. Mouse models and methods for studying human disease, acute kidney injury [ J ]. Methods Mol Biol, 2014, 1194:421-436.
3Jesse C R, Bortolatto C F, Wilhelm E A, et al. The peroxisome proliferator-activated receptor-3' agonist pioglitazone protects a- gainst eisplatin-indueed renal damage in mice[ J ]. J Appl Toxicol, 2014,34( 1 ) :25-32.
4Katagiri D, Hamasaki Y, Doi K, et al. Protection of glueagon-like peptide-1 in eisplatin induced renal injury elucidates gut-kidney connection[ J]. J Am Soc Nephro1,2013,24( 12 ) :2034-2043.
5Kerr M, Bedford M, Matthews B, et al, The economic impact of acute kidney injury in England [ J ]. Nephrol Dial Transp1,2014,29 (7) :1362-1368.
6Kellum J A, Lameire N. Diagnosis,evaluation,and management of acute kidney injury:a KDIGO summary (Part 1 ) [J]. Crit Care, 2013,17 ( 1 ) :204.
7Sahu B D, Kuncha M, Sindhura G J,et al. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage [ J ]. Phytomedicine, 2013, 20(5 ) :453-460.
8Zager R A,Johnson A C, Becker K. Plasma and urine heine oxy- genase-1 in acute kidney injury[ J]. J AM Soc Nephrol,2012,23 (6) : 1048-1057.
